GMP Auditing Services in the UK for Pharmaceutical Compliance
Regulatory inspections in the UK pharmaceutical sector leave little margin for interpretation. Documentation gaps, weak quality systems, or untested procedures can result in inspection findings that delay product release, restrict market access, or trigger enforcement action.
Inglasia Pharma Solutions provides GMP auditing services in the UK designed for pharmaceutical, biotech, and life sciences organisations that require inspection-ready quality systems. We support companies operating under MHRA, EU GMP, and PIC/S expectations by reviewing manufacturing, quality, and supply chain controls against current regulatory requirements. Our audits focus on risk exposure, procedural alignment, and evidence-based compliance, enabling senior quality leaders to address issues before they become regulatory findings.
GMP Auditing Services Across the UK Pharmaceutical Sector
Our GMP audit services are structured to reflect the realities of UK regulatory inspections, supplier oversight obligations, and internal quality governance. Each audit is scoped to product type, licence status, and operational complexity, ensuring relevance to your compliance framework.
Internal GMP Audits for UK Manufacturers
Internal audits assess the effectiveness of your pharmaceutical quality system against UK GMP guidance and EU GMP Annexes. We review SOP execution, deviation handling, CAPA effectiveness, data integrity controls, and training records. This supports early identification of systemic weaknesses that could lead to critical or major observations during MHRA inspections.
Supplier and Third-Party GMP Audits
UK licence holders remain accountable for outsourced activities. Our supplier GMP audits evaluate contract manufacturers, testing laboratories, and raw material suppliers against GMP compliance expectations. Audit outcomes provide documented assurance for vendor qualification, technical agreements, and ongoing supplier oversight.
Pre-MHRA Inspection Readiness Audits
Inspection readiness audits simulate MHRA inspection depth and questioning style. We assess site preparedness, interview key personnel, test documentation retrieval, and review inspection history trends. Findings are prioritised by regulatory risk, enabling focused remediation ahead of scheduled or unannounced inspections.
GMP Gap Analysis and Compliance Assessment
A structured GMP gap analysis benchmarks existing operations against applicable UK and EU GMP standards. This service highlights missing procedures, outdated controls, and misalignment with regulatory guidance, supporting remediation planning and resource allocation for compliance programmes.
Specialist GMP Audit Coverage and Technical Focus
Our auditing approach reflects current regulatory scrutiny areas, including data integrity, quality oversight, and supply chain governance. Audits are conducted by auditors with hands-on pharmaceutical quality experience.
Data Integrity and Computerised Systems Audits
Regulators continue to prioritise data integrity. We assess ALCOA+ principles across paper and electronic records, audit trails, access controls, and system validation. This supports compliance with MHRA data integrity guidance and reduces the risk of critical observations.
GMP Audits for Start-Up and Virtual Pharma Companies
Virtual and early-stage companies face unique GMP challenges due to outsourced manufacturing models. Our audits focus on quality agreements, oversight mechanisms, change management, and batch certification responsibilities under UK regulatory frameworks.
GMP Auditing for Clinical Trial Supply Chains
We audit GMP compliance across clinical trial manufacturing, packaging, labelling, and distribution activities. This ensures alignment with UK clinical trial regulations, Annex 13 expectations, and sponsor oversight obligations.
Remediation Support Following GMP Audit Findings
Following audits, we provide structured remediation planning aligned with regulatory expectations. This includes CAPA development, root cause analysis, and prioritisation based on inspection risk rather than administrative convenience.
Why Organisations Choose Our GMP Auditing Services in the UK
UK pharmaceutical companies operate within an increasingly scrutinised regulatory environment. Our audit methodology focuses on evidence, regulatory interpretation, and practical implementation.
Regulatory and Industry-Focused Audit Methodology
Audits are aligned with MHRA guidance, EU GMP requirements, and PIC/S standards. We apply risk-based sampling, targeted interviews, and document review techniques consistent with regulatory inspection practices.
Audit Outputs That Support Senior Decision-Making
Audit reports provide clear classification of observations, regulatory references, and impact assessment. This enables quality leaders to justify remediation priorities, budget allocation, and governance decisions.
Industry Statistics That Matter
Over 60% of MHRA inspection findings relate to quality systems and data integrity controls.
Supplier oversight deficiencies remain a leading cause of major GMP observations in UK inspections.
Organisations conducting routine internal GMP audits reduce critical inspection findings by up to 40%.
FAQs About GMP Auditing Services in the UK
How do your GMP audits align with MHRA expectations?
Audits reference current MHRA guidance, EU GMP chapters, and inspection trend data to reflect regulator focus areas.
Can audits be scoped to specific GMP activities?
Yes. Audits can focus on manufacturing, quality control, validation, supply chain oversight, or specific Annex requirements.
Do you audit both licensed and non-licensed facilities?
We audit licensed manufacturers, contract sites, and non-licensed facilities involved in GMP-related activities.
How long does a typical GMP audit take?
Duration depends on site complexity and scope, typically ranging from one to five days.
Are audit reports suitable for regulatory submission?
Reports are structured to support regulatory inspections, supplier qualification, and internal governance review.
Do you support follow-up audits after remediation?
Yes. Follow-up audits verify CAPA effectiveness and sustained compliance.
Can audits support merger or acquisition due diligence?
GMP audits are frequently used to assess compliance risk during pharmaceutical transactions.
Work With GMP Auditing Specialists Focused on UK Compliance
Strong GMP governance relies on accurate assessment and regulatory-aligned oversight. Our GMP auditing services in the UK provide clarity on compliance status and inspection risk.